Dompé
Manufacturing · Italy · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
San Martino 12-12a, Milano, Lombardy, 20...Phone Number
(833) 366-7387Website
www.dompe.comRevenue
$1.5 BillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
5
1
1
1
1
About Dompé
Dompé is a pharmaceutical company with over 130 years of experience, dedicated to advancing drug and technology developments to create innovative treatments. They focus on therapeutic areas such as ophthalmology, primary care, and pain management, utilizing their advanced supercomputing platform for drug screening. Their manufacturing hub in L'Aquila, Italy, produces both over-the-counter drugs and specialized biotech treatments. Dompé aims to positively impact patients' lives through their commitment to research and development in complex therapeutic areas.Explore more
Dompé Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dompé your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Dompé has new funding data
Click to see if Dompé had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Dompé launches new products
Dompé, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Dompé recently announced quarterly report
Check if Dompé has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Dompé
Check out if Dompé is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Dompé is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dompé is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dompé.
Dompé Tech Stack
A closer look at the technologies used by Dompé
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
Contracts
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Dompé News & Media
JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies - Eli Lilly and Company, Incyte Corporation, Dompé Farmaceutici S.p.A, Sanofi, Celgene, AstraZeneca, Karyopharm Therapeutics
The JAK inhibitor market is poised for robust growth in the coming years, driven by expanding applications across autoimmune diseases and oncology. With ongoing advancements in drug development and increasing awareness among healthcare professionals, the market is anticipated to witness significant expansion. Moreover, the rising prevalence of inflammatory disorders globally further fuels the demand for JAK inhibitors, fostering a promising landscape for market growth. The JAK inhibitor market iSjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
The Sjogren's syndrome market is expected to be mainly driven by the increasing prevalence of the disease, along with the promising emerging pipeline therapies with a new mechanism of action, will fuel the Sjogren's syndrome market. LAS VEGAS, Jan. 16, 2024 /PRNewswire/ -- DelveInsight's...Dompé farmaceutici Appoints Shannon K. Sullivan as Chief Commercial Officer Biotech
MILAN, Italy & SAN MATEO, Calif.--(BUSINESS WIRE)-- #biotech--Dompé, a leading biopharmaceutical company with operations in Italy and the US, appointed Shannon K. Sullivan as Chief Commercial Officer (CCO).Dompé Foundation Doubles Its Funding for Rita Levi Montalcini fellowships in Neuroscience and Neurobiology
WASHINGTON--(BUSINESS WIRE)-- #biotech--The Dompé Foundation has announced it doubled to 1 million dollars its support to MA, PhD and post-doc candidates from United States-based universities for 2023. This funding opportunity, which honors the legacy of the only female Italian Nobel laureate in Medicine, is intended for students of any nationality that have already been admitted to a MA, PhD or post-doc program in Neuroscience and Neurobiology at a US university. As with former grants, the
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dompé
Sign Up For FreeTo access detailed company insights
Dompé is a pharmaceutical company with over 130 years of experience, dedicated to advancing drug and technology developments to create innovative treatments. They focus on therapeutic areas such as ophthalmology, primary care, and pain management, utilizing their advanced supercomputing platform for drug screening. Their manufacturing hub in L'Aqui... Read More
